Turnbull D M, Howel D, Rawlins M D, Chadwick D W
Br Med J (Clin Res Ed). 1985 Mar 16;290(6471):815-9. doi: 10.1136/bmj.290.6471.815.
A series of 140 previously untreated patients with tonic-clonic or partial seizures were randomised to receive either phenytoin or sodium valproate. There was no difference between the treatment groups in pretreatment variables that might influence outcome. Sodium valproate and phenytoin in the treatment of tonic-clonic or partial seizures showed no difference in efficacy as regards time to two year remission or time to first seizure. When the possible prognostic factors were studied, including history and results of clinical examination and investigations before treatment; the only factor which influenced the proportion of patients achieving two year remission was type of seizure. Patients with a clinical history of partial seizures did significantly less well than those with a history of tonic-clonic seizures only. This study showed no major difference in efficacy between sodium valproate and phenytoin in adults with recent onset of epilepsy, irrespective of the type of seizures that the patient suffered.
140名既往未接受过治疗的强直阵挛性发作或部分性发作患者被随机分组,分别接受苯妥英钠或丙戊酸钠治疗。在可能影响治疗结果的预处理变量方面,治疗组之间没有差异。丙戊酸钠和苯妥英钠在治疗强直阵挛性发作或部分性发作时,在达到两年缓解时间或首次发作时间方面疗效无差异。在研究包括治疗前病史、临床检查及检查结果等可能的预后因素时,唯一影响达到两年缓解的患者比例的因素是发作类型。有部分性发作临床病史的患者比仅有强直阵挛性发作病史的患者预后明显要差。这项研究表明,对于近期发病的成人癫痫患者,无论其所患癫痫发作类型如何,丙戊酸钠和苯妥英钠在疗效上没有重大差异。